Astrana Health Overview
Astrana Health Target Price
Analysts' 12-month price predictions for ASTH.
Get informed when a big investor buys or sells
+ FollowShare Price
$49
Average Target Price
$43.33
11.6% downside
11.6% downside6 analysts in the last 4 months
High: $50 | Low: $37
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | Barclays | $50 |  2% upside |  |
| 2026-05-14 | Truist Financial | $47 | 4.1% downside | |
| 2026-05-11 | Barclays | $37 | 24.5% downside | |
| 2026-05-08 | NeedhamMatthew Shea | $41 | 16.3% downside | |
| 2026-05-08 | Robert W. Baird | $45 | 8.2% downside | |
| 2026-04-15 | Robert W. Baird | $40 | 18.4% downside | |
| 2026-02-02 | BTIG | $40 | 18.4% downside | |
| 2025-12-12 | NeedhamMatthew Shea | $28 | 42.9% downside | |
| 2025-11-25 | Jefferies | $37 | 24.5% downside | |
| 2025-11-24 | BarclaysAndrew Mok | $26 | 46.9% downside | |
| 2025-04-01 | Barclays | $36 | 26.5% downside | |
| 2025-03-03 | Robert W. Baird | $50 | 2% upside | |
| 2024-10-03 | BTIGDavid Larsen | $70 | 42.9% upside | |
| 2024-08-15 | Robert W. BairdMichael Ha | $67 | 36.7% upside | |
| 2024-06-27 | Stifel NicolausChris O'Cull | $48 | 2% downside | |